Literature DB >> 17625033

Chronic facial pain following injection of sodium tetradecyl sulphate into an intraparotid haemolymphangioma.

D P Crampsey1, L Cochrane, D Roebuck, B E Hartley.   

Abstract

OBJECTIVE: We report a rare case of chronic facial pain following sclerotherapy for intraparotid haemolymphangioma, thereby highlighting an important clinical consideration when advising this treatment option as an alternative to surgery in the head and neck.
METHOD: Case report, with a review of relevant literature.
RESULTS: Sclerotherapy of lymphangiomata is well reported in the literature. Unusually, our young patient with an intraparotid haemolymphangioma experienced severe, chronic pain following intralesional injection of sodium tetradecyl sulphate, which required management by a specialist pain service. We discuss the technique of sclerotherapy for such lesions, and also discuss the potential side effects of two agents commonly used in our centre: OK 432 and sodium tetradecyl sulphate.
CONCLUSION: Non-surgical treatments of lymphangiomata and venous vascular malformations are not without complication. Both patient and clinician should be aware of this, and of the other potential side effects of sclerotherapy, prior to its use in the head and neck.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17625033     DOI: 10.1017/S0022215107009590

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  1 in total

1.  In vivo biocompatibility of the PLGA microparticles in parotid gland.

Authors:  Mario Cantín; Patricio Miranda; Iván Suazo Galdames; Daniela Zavando; Patricia Arenas; Luis Velásquez; Cristian Vilos
Journal:  Int J Clin Exp Pathol       Date:  2013-10-15
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.